News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,784 Results
Type
Article (88207)
Company Profile (823)
Press Release (784733)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233356)
Career Advice (4152)
Deals (39899)
Drug Delivery (158)
Drug Development (91484)
Employer Resources (205)
FDA (18445)
Job Trends (17442)
News (398152)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (166)
Alliances (56982)
ALS (193)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (381)
Approvals (18642)
Artificial intelligence (688)
Autoimmune disease (204)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (70)
Breast cancer (697)
Cancer (5372)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77466)
Collaboration (1973)
Company closure (6)
Compensation (1248)
Complete response letters (83)
COVID-19 (3005)
CRISPR (110)
C-suite (977)
Cystic fibrosis (157)
Data (6742)
Decentralized trials (2)
Denatured (77)
Depression (166)
Diabetes (556)
Diagnostics (7334)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (335)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (260)
Earnings (100829)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135957)
Executive appointments (1076)
FDA (21830)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1660)
Gene editing (234)
Generative AI (71)
Gene therapy (724)
GLP-1 (1172)
Government (5486)
Grass and pollen (8)
Guidances (389)
Healthcare (20985)
HIV (76)
Huntington's disease (56)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (77)
Indications (135)
Infectious disease (3324)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (717)
Lymphoma (397)
Machine learning (49)
Management (66)
Manufacturing (933)
MASH (186)
Medical device (15100)
Medtech (15168)
Mergers & acquisitions (23052)
Metabolic disorders (1493)
mRNA (202)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (391)
Neuropsychiatric disorders (110)
Neuroscience (3268)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (731)
Opinion (350)
Ovarian cancer (177)
Pain (235)
Pancreatic cancer (254)
Parkinson's disease (322)
Partnered (39)
Patents (550)
Patient recruitment (559)
Peanut (65)
People (67196)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23934)
Phase 2 (33617)
Phase 3 (25321)
Pipeline (6234)
Policy (360)
Postmarket research (3554)
Preclinical (10732)
Press Release (72)
Prostate cancer (273)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1028)
Real estate (7445)
Recruiting (81)
Regulatory (29384)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1194)
Venture capital (103)
Weight loss (498)
Women's health (107)
Worklife (23)
Date
Today (9)
Last 7 days (750)
Last 30 days (3011)
Last 365 days (32700)
2026 (6100)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51712)
Australia (9086)
California (12291)
Canada (3496)
China (1240)
Colorado (519)
Connecticut (537)
Delaware (364)
Europe (119017)
Florida (1823)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1027)
India (82)
Indiana (576)
Iowa (24)
Japan (471)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1524)
Massachusetts (9020)
Michigan (381)
Minnesota (695)
Mississippi (7)
Missouri (146)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3304)
New Mexico (33)
New York (3236)
North Carolina (1691)
North Dakota (10)
Northern California (5949)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2448)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4766)
Tennessee (194)
Texas (1938)
United States (44216)
Utah (370)
Vermont (1)
Virginia (310)
Washington D.C. (88)
Washington State (1017)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,784 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
March 9, 2026
·
16 min read
Press Releases
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
March 9, 2026
·
7 min read
Press Releases
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
March 9, 2026
·
2 min read
Press Releases
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 9, 2026
·
8 min read
Press Releases
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
March 9, 2026
·
10 min read
Press Releases
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
March 9, 2026
·
6 min read
Press Releases
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
March 9, 2026
·
6 min read
Press Releases
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
March 9, 2026
·
12 min read
Cancer
5 Therapies Moving the Multiple Myeloma Space Forward
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told
BioSpace
. Here are five therapies that could change the treatment paradigm.
March 9, 2026
·
8 min read
·
Tristan Manalac
FDA
FDA’s Prasad To Depart FDA Following Tumultuous Term as CBER Chief
Center for Biologics Evaluation and Research Director Vinay Prasad will exit the FDA for the second time after a controversial run that saw the oncologist butt heads with colleagues and ruffle feathers in biopharma after presiding over the rejection of several rare disease therapies.
March 6, 2026
·
3 min read
·
Heather McKenzie
1 of 87,379
Next
